Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03KKK
|
||||
| Former ID |
DNC011840
|
||||
| Drug Name |
1,3-Dipropyl-3,7-dihydro-purine-2,6-dione
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [533429] | ||
| Formula |
C11H16N4O2
|
||||
| Canonical SMILES |
CCCN1C2=C(C(=O)N(C1=O)CCC)NC=N2
|
||||
| InChI |
1S/C11H16N4O2/c1-3-5-14-9-8(12-7-13-9)10(16)15(6-4-2)11(14)17/h7H,3-6H2,1-2H3,(H,12,13)
|
||||
| InChIKey |
MJVIGUCNSRXAFO-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Adenosine A2b receptor | Target Info | Inhibitor | [533429] | |
| Adenosine A1 receptor | Target Info | Inhibitor | [533429] | ||
| Adenosine A2a receptor | Target Info | Inhibitor | [533429] | ||
| KEGG Pathway | Rap1 signaling pathway | ||||
| Calcium signaling pathway | |||||
| Neuroactive ligand-receptor interaction | |||||
| Vascular smooth muscle contraction | |||||
| Alcoholismhsa04022:cGMP-PKG signaling pathway | |||||
| cAMP signaling pathway | |||||
| Sphingolipid signaling pathway | |||||
| Morphine addictionhsa04015:Rap1 signaling pathway | |||||
| Parkinson's disease | |||||
| Alcoholism | |||||
| Pathway Interaction Database | C-MYB transcription factor networkhif2pathway:HIF-2-alpha transcription factor network | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.